Dental management considerations for the patient with an acquired coagulopathy. Part 2: Coagulopathies from drugs

被引:64
作者
Lockhart, PB
Gibson, J
Pond, SH
Leitch, J
机构
[1] Carolinas Med Ctr, Dept Oral Med, Charlotte, NC 28232 USA
[2] Glasgow Dent Hosp & Sch, Glasgow G2 3JZ, Lanark, Scotland
[3] GDP, Kelso, WA USA
[4] Royal Coll Physicians & Surg, Ottawa, ON, Canada
[5] Univ Glasgow, Glasgow Dent Hosp & Sch, Glasgow G12 8QQ, Lanark, Scotland
关键词
D O I
10.1038/sj.bdj.4810660
中图分类号
R78 [口腔科学];
学科分类号
1003 [口腔医学];
摘要
Dental patients often give a medical history that suggests the possibility of a coagulopathy from drugs, with a corresponding risk for prolonged bleeding during and following an invasive procedure. Identification of patients who may be prone to oral bleeding requires specific medical history information and the proper use of laboratory tests. Some NSAIDs are reported to cause prolonged oral bleeding, but scientific evidence is lacking. Likewise, the risk of oral bleeding from anticoagulants such as warfarin is often over stated, and unnecessary adjustment of NSAID or warfarin dosage puts patients at risk for significant morbidity and mortality. Some commonly employed laboratory tests such as the prothrombin time provide helpful information when used in the appropriate setting, but others, such as the bleeding time test, provide little or no predictive value in the determination of patients at risk for oral bleeding. Dental management of patients with potential coagulopathies from medications requires an understanding of basic principles of coagulation. The vast majority of these patients can be managed in the community setting without risk and without alteration of anticoagulant drug regimes.
引用
收藏
页码:495 / 500
页数:6
相关论文
共 24 条
[1]
ASPIRIN-INDUCED PROLONGATION OF BLEEDING-TIME AND PERIOPERATIVE BLOOD-LOSS [J].
AMREIN, PC ;
ELLMAN, L ;
HARRIS, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 245 (18) :1825-1828
[2]
THE BLEEDING-TIME AS A PREOPERATIVE SCREENING-TEST [J].
BARBER, A ;
GREEN, D ;
GALLUZZO, T ;
TSAO, CH .
AMERICAN JOURNAL OF MEDICINE, 1985, 78 (05) :761-764
[3]
PLATELETS AND THROMBOLYTIC THERAPY [J].
COLLER, BS .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (01) :33-42
[4]
RELATIONSHIPS BETWEEN THROMBOXANE PRODUCTION, PLATELET AGGREGABILITY, AND SERUM CONCENTRATIONS OF IBUPROFEN OR FLURBIPROFEN [J].
COX, SR ;
VANDERLUGT, JT ;
GUMBLETON, TJ ;
SMITH, RB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (05) :510-521
[5]
DECATERINA R, 1994, BLOOD, V84, P3363
[6]
FERRARIS VA, 1983, SURG GYNECOL OBSTET, V156, P439
[7]
THE CLINICAL IMPORTANCE OF ACQUIRED ABNORMALITIES OF PLATELET-FUNCTION [J].
GEORGE, JN ;
SHATTIL, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (01) :27-39
[8]
Gewirtz AS, 1996, ARCH PATHOL LAB MED, V120, P353
[9]
IMPROVEMENT IN EARLY SAPHENOUS-VEIN GRAFT PATENCY AFTER CORONARY-ARTERY BYPASS-SURGERY WITH ANTIPLATELET THERAPY - RESULTS OF A VETERANS ADMINISTRATION COOPERATIVE STUDY [J].
GOLDMAN, S ;
COPELAND, J ;
MORITZ, T ;
HENDERSON, W ;
ZADINA, K ;
OVITT, T ;
DOHERTY, J ;
READ, R ;
CHESLER, E ;
SAKO, Y ;
LANCASTER, L ;
EMERY, R ;
SHARMA, GVRK ;
JOSA, M ;
PACOLD, I ;
MONTOYA, A ;
PARIKH, D ;
SETHI, G ;
HOLT, J ;
KIRKLIN, J ;
SHABETAI, R ;
MOORES, W ;
ALDRIDGE, J ;
MASUD, Z ;
DEMOTS, H ;
FLOTEN, S ;
HAAKENSON, C ;
HARKER, LA .
CIRCULATION, 1988, 77 (06) :1324-1332
[10]
LIND SE, 1991, BLOOD, V77, P2547